This is Moderna's UK website
It may contain content that is not applicable to your location
Responsibility
In line with our commitment to transparency and the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, Moderna reports the details of our financial relationships with various stakeholders in the UK.
Disclosures of Moderna’s payments made to healthcare professionals (HCPs), healthcare organisations (HCOs), patient organisations and members of the public can be found below.
All reasonable steps have been taken to ensure the accuracy of this information. If you believe any details require correction, please contact wecare@modernatx.com.
Working with HCPs and HCOs
Moderna works with the NHS, other HCOs and HCPs to help us deliver better outcomes for the UK public and the HCPs who care for them. These projects are founded on shared objectives, transparent governance and clearly defined roles to ensure they deliver that could not be achieved by either party alone.
Transfers of value with HCPs and HCOs for 2023, 2024 and 2025 are published on the ABPI Disclosure UK database along with Moderna’s Methodological Note, for each respective year, which outlines our methodologies for preparing the disclosures and identifying each category of transfer of value.
Patient Organisations
Moderna believes in working openly with patient organisations to ensure the patient voice informs our approach every step of the way. Details of funding provided to patient organisations for 2025, 2024 and 2023 are available below.
Members of the Public
Details of funding provided to patients, journalists and other members of the UK public in 2024 can be viewed below.
